This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Idorsia Pharmaceuticals Ltd. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Rémy Castro: Innovator in Pharmaceutical Chemistry
Introduction
Rémy Castro is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medicinal use. His work focuses on innovative solutions that address critical health issues.
Latest Patents
Rémy Castro holds a patent for his invention titled "8-(piperazin-1-yl)-1,2,3,4-tetrahydro-isoquinoline derivatives." This invention relates to compounds of Formula (I), wherein R, R, R, R, and R are as described in the detailed description. The patent also covers pharmaceutically acceptable salts of these compounds and their use as medicaments, especially as modulators of the CXCR3 receptor. He has 1 patent to his name.
Career Highlights
Rémy Castro is currently employed at Idorsia Pharmaceuticals Ltd., a company known for its commitment to innovative drug development. His role involves extensive research and development, contributing to the advancement of new therapeutic options.
Collaborations
Throughout his career, Rémy has collaborated with esteemed colleagues, including Emmanuel Meyer and Eva Caroff. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Rémy Castro's work exemplifies the impact of innovative thinking in pharmaceutical chemistry. His contributions continue to pave the way for advancements in medical treatments and therapies.